Detailed Study Notes on Compromised Neonates

Compromised Neonates

Presentation by: Tesa Morales, MSN, RN, RNC-MNN

Newborn Birth Injuries

Types of Injuries

  • Fractured Clavicle: Common injury during delivery.
  • Caput Succedaneum: Swelling of the soft tissues on the baby's head due to pressure during birth.
  • Cephalohematoma: Bleeding between the skull and its periosteum; does not cross suture lines.
  • Brachial Plexus Injury:
    • Caused by nerves being damaged due to pressure, stretching, tearing, or cutting during delivery.
    • This injury affects communication between the brain and muscles.

Brachial Plexus Birth Injury

  • Definition: An injury to the brachial plexus nerves occurring in approximately one to three out of every 1,000 births.
  • Causes: Stretching, compression, or tearing of brachial plexus nerves during a difficult delivery.
  • Effects: Potential paralysis or loss of muscle function in the upper arm.
  • Injury Breakdown:
    • Upper Brachial Plexus (C5, C6): Affects shoulder and elbow muscles.
    • Lower Brachial Plexus (C7, C8, T1): Affects forearm and hand muscles.
  • Erb's Palsy:
    • Involves the upper portion (C5, C6, C7) of the brachial plexus, leading to weakness in shoulder and biceps muscles.
    • Home physical therapy should begin at three weeks of age to prevent complications like stiffness and shoulder dislocation.

Other Newborn Birth Injuries

Forceps Delivery Injuries

  • Risks Associated with Forceps Use:
    • Eye trauma
    • Facial palsy: Muscle weakness in the face
    • Facial injuries due to pressure
    • Skull fractures leading to potential brain bleeding
    • Possible seizures and brain damage
    • Nerve damage, including facial nerves

Compromised Newborns

Classification of Pre-term Infants

  • Definition: Infants born prematurely before 37 weeks of gestation.
    • Late Pre-term: Born between 34 and 36 weeks.
    • Moderately Pre-term: Born between 32 and 34 weeks.
    • Very Pre-term: Born at less than 32 weeks.

Meconium Aspiration Syndrome

  • Definition: Condition where a newborn inhales a mixture of meconium (fetal stool) and amniotic fluid.
  • Causes: The exact reason for pre-birth stool release is not fully understood but is more common in:
    • Full-term newborns who are small for gestational age.
    • Post-term babies (after 42 weeks).
  • Observation: Healthcare providers check amniotic fluid for meconium at birth; most cases resolve within days.

Transient Tachypnea of the Newborn (TTN)

  • Onset: Occurs soon after birth (1-2 hours).
  • Symptoms:
    • Rapid, noisy breathing (grunting)
    • Use of accessory muscles for breathing (e.g., nasal flaring, retractions)
  • Treatment:
    • Oxygen support
    • IV fluids
    • Antibiotics (ABX)

Hyperbilirubinemia

  • Incidence: Common in term newborns; up to 60% show signs of clinical jaundice within the first week.
  • Pathophysiology: Can be physiological or pathological; related to several other conditions:
    • Physiological Jaundice: Usually benign, resolves within 1 week for full-term infants, extends to 2 weeks in preterms.
    • Pathological Jaundice: Associated with significant illnesses (e.g., hemolytic disease, liver abnormalities, infections).
    • Breastfeeding jaundice and hemolytic jaundice (e.g., due to Rh or ABO incompatibility).

Risk Factors for Hyperbilirubinemia

  • Neonatal Factors:
    • Birth trauma: e.g., cephalohematoma, bruising, instrument delivery.
    • Drugs: e.g., Pediazole, chloramphenicol.
    • Male gender, infections (TORCH), prematurity, previous sibling with the condition.
  • Maternal Factors:
    • ABO/Rh incompatibility, certain drugs (e.g., oxytocin), breastfeeding.
    • Ethnicity (higher in Asians, Native Americans), maternal illnesses (e.g., gestational diabetes).

Diagnostic Criteria for Hyperbilirubinemia

  • Low Risk Infants:
    • At 38 weeks gestation without risk factors.
  • Medium Risk Infants:
    • At 38 weeks with risk factors or between 35-37 weeks without risk factors.
  • High Risk Infants:
    • Born at or before 35 weeks with risk factors.

Treatment Protocols

  • Phototherapy Initiation:
    • For Low Risk: Total Bilirubin > 12 mg/dL between 24-48 hours, > 15 mg/dL between 48-72 hours, > 18 mg/dL after 72 hours.
    • For Medium Risk: Total Bilirubin > 10 mg/dL between 24-48 hours, > 13 mg/dL between 48-72 hours, > 15 mg/dL after 72 hours.
    • For High Risk: Total Bilirubin > 8 mg/dL between 24-48 hours.

Pathophysiology of Hyperbilirubinemia

  • Overview:
    • Increased hematocrit levels but shorter RBC lifespan in newborns.
    • Newborn livers: Inefficient in conjugating and excreting bilirubin into the intestinal tract.
    • Resolution: Total bilirubin levels do not rise faster than 0.2 mg/dL/hr or 5 mg/dL/day, and typically resolve without complication.

ABO Incompatibility

  • Scenario: Mother blood type O; Baby blood types A or B.
  • Mechanism: Presence of anti-A and anti-B antibodies from the mother can lead to hemolysis.
  • Antigen Similarity: A and B antigens may resemble common environmental antigens, triggering immune response against fetal blood cells.

Treatment for Hyperbilirubinemia

  • Methods:
    • Phototherapy
    • Use of fiberoptic blankets
    • Exchange transfusion for serious cases
    • Temporary cessation of breastfeeding may be advised.

Nursing Care for Hyperbilirubinemia

  • Focus Areas:
    • Feeding and nutrition assessment
    • Skin care
    • Maintenance of thermoregulation
    • Eye care assessments
    • Routine blood laboratory tests

Effects of Bilirubin Toxicity

  • Symptoms: Early and late effects include:
    • Lethargy, irritability, poor feeding, and seizures.
    • High-pitched cry, hypotonia, and apnea.
    • Potential for chronic complications like hearing loss, dental dysplasia, and impaired cognitive function.

Compromised Newborns from Diabetic Mothers

Pathophysiology

  • Caused by maternal hyperglycemia leading to increased fetal insulin production, which promotes somatic growth.

Risks Associated with Infants of Diabetic Mothers

  • Conditions: Macrosomia, birth trauma, respiratory distress syndrome (RDS), hypoglycemia, hypocalcemia, polycythemia, and hyperbilirubinemia.
  • Nursing Interventions:
    • Monitor blood sugar levels.
    • Assess signs of hypoglycemia and increased oxygen needs.
    • Conduct full head-to-toe assessments and assist with feeding plans.

Abnormalities in Fetal Size

Fetal Macrosomia vs Intrauterine Growth Restriction (IUGR)
  • Macrosomia: Birth weight exceeding 4000 to 4500 g (8 lb 13 oz to 10 lbs).
  • IUGR: Fetus small for gestational age (<10th percentile for birth weight); may be caused by various maternal, placental, or fetal factors.

Risk Factors for Fetal Macrosomia

  • Determinants:
    • Gestational diabetes, maternal obesity, excessive maternal weight gain, histories of macrosomia, and prolongation of pregnancy.
    • Environmental factors like ethnicity and multiparity.

Complications of Fetal Macrosomia

  • Risks include cephalopelvic disproportion (CPD), birth trauma, postpartum hemorrhage, meconium aspiration, and shoulder dystocia leading to potential brachial plexus injuries and fractures.

Nursing Care for Fetal Macrosomia

  • Monitoring: Fetal heart rate, signs of compromise; emotional support for mothers; observation for signs of Erb’s palsy, cephalohematoma, or fractured clavicle.
  • Management Strategies: Cesarean section if necessary and proper postpartum monitoring.

Intrauterine Growth Restriction (IUGR)

Risk Factors

  • Include inadequate gestational weight gain, poor nutrition, maternal substance abuse, and underlying health conditions like hypertension.

Complications of IUGR

  • Possible outcomes include asphyxia, meconium aspiration syndrome, cognitive difficulties, hypoglycemia, and intrauterine infections.

Management Strategies for IUGR

  • Focused on early recognition and medical intervention for future problems.

Amniotic Fluid Disorders

Oligohydramnios

  • Condition characterized by low amniotic fluid volume for gestational age.

Polyhydramnios

  • Excessively high levels of amniotic fluid surrounding the fetus during pregnancy.

Fetal Demise

Definition and Incidence

  • Fetal Demise: Occurs in roughly 1% of all normal, uncomplicated pregnancies leading to intrauterine fetal demise (IUFD).
  • Possible Causes: Often unknown; can be linked to umbilical cord issues, placental problems, defects, continued pregnancies beyond 42 weeks, maternal diabetes, hypertension, etc.

Complications of Fetal Demise

  • Risks include disseminated intravascular coagulation (DIC), infections, increased bleeding from the retained fetal parts.

Clinical Presentation

  • Signs include absent fetal heart tones, small size for dates, and absence of fetal movements, often confirmed via ultrasound.

Management of Fetal Demise

  • Treatment should be performed within two weeks of diagnosis, often preferring early removal of uterine contents.
  • Antibiotics and Rhogam may be administered as appropriate.

Patient Teaching for Fetal Demise

  • Restrictions based on delivery choice, avoiding intercourse for 4-6 weeks, and general care instructions.

Nursing Management for Fetal Demise

  • Focus on emotional support, coping, assisting with the grieving process, and providing accurate information.

Conclusion

Importance of Awareness

  • October is Pregnancy & Infant Loss Awareness Month, recognizing that 1 in 4 women will experience miscarriage, stillbirth, or infant loss.

"When a rainbow appears, it doesn't mean the storm never existed or that you are not still dealing with its impact. It means something beautiful has appeared amid the darkness as a sign of hope for what's yet to come."

  • Unknown

THE END